様々な臨床応用におけるケタミン投与戦略の最適化:包括的なレビュー
Ahmed M Kedwany1, Reem Sayad1, Nada S Jibril2
1Faculty of Medicine, Assiut University, Assiut, Egypt.
Annals of medicine and surgery (2012)
|September 3, 2025
まとめ
ケタミンは麻酔,痛み,精神疾患に多用途の薬です. 患者の要因に基づいてケタミン投与量を個別化することは,有効性と安全性のバランスをとる上で極めて重要です.
科学分野:
- 薬理学について
- 臨床医学
- 神経科学
背景:
- ケタミンは,麻酔,痛み管理,精神疾患で広く使用される薬です.
- 静脈内,筋肉内,鼻内,口内など,様々な投与経路に及ぶ.
研究 の 目的:
- 異なる投与経路におけるケタミン の臨床的有用性を検討する.
- ケタミンの用量調整の重要性を強調する.
- ケタミンの投与量に影響を与える要因とその治療結果への影響を分析する.
主な方法:
- ケタミンの臨床試験に関する文献レビュー
- 患者の特徴と併用薬を含むケタミン投与に影響を与える要因の分析
- 投与量,輸液速度,投与頻度の有効性および安全性への影響の評価
主要な成果:
- ケタミンの治療効果は用量に依存し,投与方法,速度,頻度によって影響を受けます.
- ケタミンの効能と潜在的な副作用のバランスをとるには,個別の投与が重要です.
- 患者の特徴,併発症,および併用薬は,最適な用量に影響します.
結論:
- ケタミンの治療を最適化するために,患者特有の要因に合わせた個別化された投与レジミンは不可欠です.
- 長期的な影響,代替路線,個別化されたアプローチに関する知識のギャップを埋めるためにさらなる研究が必要である.
- 標準化されたプロトコルを開発し,新しい戦略を探求することで ケタミンの治療的可能性と安全性を高めることができます.
さらに関連する動画
09:18Intraventricular Drug Delivery and Sampling for Pharmacokinetics and Pharmacodynamics Study
Published on: March 31, 2022
2.8K
05:42Elevated Plus Maze Test Combined with Video Tracking Software to Investigate the Anxiolytic Effect of Exogenous Ketogenic Supplements
Published on: January 7, 2019
31.6K
関連する概念動画
00:59Nonlinear Pharmacokinetics: Drug Elimination for IV Bolus Injection
148
In pharmacokinetics, the elimination rate of a drug following a capacity-limited model is primarily controlled by two parameters: Vmax and KM. These parameters are crucial in how the drug behaves inside the body after administration.
Following the administration of a single intravenous (IV) bolus injection, we can determine the concentration of the drug in the plasma at any given time. This calculation is achieved using a specific equation that integrates the values of Vmax and KM.
We can also...
Following the administration of a single intravenous (IV) bolus injection, we can determine the concentration of the drug in the plasma at any given time. This calculation is achieved using a specific equation that integrates the values of Vmax and KM.
We can also...
148
01:23Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
293
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
293
01:20Determination of Michaelis Constant and Maximum Elimination Rate
171
The Michaelis constant (KM) and the theoretical maximum process rate (Vmax) are vital parameters in the Michaelis-Menten equation, central to many biochemical reactions. They provide essential insights into enzyme kinetics and drug metabolism.
These parameters can be estimated by analyzing plasma concentration data post-drug administration. A notable example of this application is phenytoin, a drug with capacity-limited kinetics. It's recommended that phenytoin should be administered at two...
These parameters can be estimated by analyzing plasma concentration data post-drug administration. A notable example of this application is phenytoin, a drug with capacity-limited kinetics. It's recommended that phenytoin should be administered at two...
171
01:24Parenteral Anesthetics: Overview
196
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
196
01:11Renal Failure: Dose Adjustments
152
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
152
01:21Factors Affecting Drug Response: Overview
2.4K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.4K